Skip to content
Our vital research improves the lives of millions of New Zealanders living with respiratory and cardiac disease.
1 in 5
die from heart disease
1 in 6
live with respiratory disease
$25b
cost to the country every year

Respiratory Impact Reports

Respiratory Impact Report mock up

For more than 20 years, our reports have tracked the burden of respiratory disease in Aotearoa.

Lung cancer screening

Lung cancer screening - CT scan

Lung cancer is NZ's deadliest cancer, yet we have no national screening programme. We're calling on that to change, now.

Train-the-Trainers vaping education

Sharon Pihema - Train-the-Trainers vaping education session - Wainuiomata 2026

Develop practical skills to deliver trusted youth vaping education through our Train-the-Trainers programme.

Asthma in schools

School kids

Support safer schools with asthma emergency kits, school inhaler guidance and practical education resources.

New report reveals children and elderly bear the brunt of respiratory disease

Baby and grandparent holding hands

Respiratory hospitalisations in NZ have risen 16%, prompting calls for urgent action to protect vulnerable communities.

Heart devices don't work like pills, so why do we try to fund them that way?

iStock-2157517583

Heart tech moves as fast as consumer electronics, but NZ still assesses and funds it through a process built for pills.

More than just a weight loss drug - the connection between GLP-1s and the heart

GLP-1 medication

Could GLP-1 medicines do more than help you lose weight? A cardiologist explains their potential to protect the heart.